We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Green Tea Holds Potential as Therapy for Inflammatory Skin Diseases

By Biotechdaily staff writers
Posted on 13 Aug 2007
Green tea could hold promise as a new treatment for skin and autoimmune disorders such as psoriasis and dandruff.

Researchers examined an animal model for inflammatory skin diseases, which are frequently characterized by patches of dry, red, flaky skin caused by the inflammation and overproduction of skin cells. More...
Those treated with green tea showed slower growth of skin cells and the presence of a gene that regulates the cells' life cycles.

"Psoriasis, an autoimmune disease, causes the skin to become thicker because the growth of skin cells is out of control,” stated Dr. Stephen Hsu, an oral biologist in the Medical College of Georgia (MCG; Augusta, USA) School of Dentistry and lead investigator on the study, which was published in the August 18, 2007, issue of the journal Experimental Dermatology. "In psoriasis, immune cells, which usually protect against infection, instead trigger the release of cytokines, which causes inflammation and the overproduction of skin cells.” Other autoimmune diseases with similar side effects include lupus, which can lead to skin lesions and dandruff.

Green tea, already shown to inhibit inflammation, helps by regulating the expression of caspase-14, a protein in genes that regulates the life cycle of a skin cell. "That marker guides cells by telling them when to differentiate, die off, and form a skin barrier,” Dr. Hsu noted. "In people with psoriasis, that process is interrupted and the skin cells don't die before more are created and the resulting lesions form.”

Lab animals treated with green tea also demonstrated decreased levels of proliferating cell nuclear antigen (PCNA), a gene expressed when skin cells multiply. In psoriasis, the gene is overexpressed and speeds production of skin cells.

"Before treatment, the antigen, PCNA, was present in all layers of the skin,” Dr. Hsu said. "Typically, PCNA is only found in the basal layer, the innermost layer where skin cells continually divide and new cells push the older ones to the skin surface, where they eventually slough off. After being treated with green tea, the animal models showed near-normal levels of PCNA in only the basal layers.”

This study is significant, according to Dr. Hsu, because some treatments for psoriasis and dandruff can have hazardous side effects. "The traditional treatment of ultraviolet light and medication, while it can control the lesions and be used long term, may cause squamous cell carcinoma--the second most common form of skin cancer,” Dr. Hsu said. "Some of the most effective anti-dandruff shampoos also have carcinogens in them. While the U.S. Food and Drug Administration allows that in small amounts, the bottom line is that we don't know the long-term effects of using those products continuously.”

Green tea, which is plant-derived, may be an option, according to Dr. Hsu. But scientists must work to overcome some barriers with the treatment. The compounds in green tea are so active that they are oxidized too rapidly when combined with other ingredients. They also dissolve in water, which cannot penetrate the skin's barrier. Researchers are looking for a balanced formula that can dissolve in fats, which can permeate the skin.


Related Links:
Medical College of Georgia

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.